The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza a H5N1 and H5N2 vaccines

Journal of Microbiology and Biotechnology

Volumn 21, Issue 4, 2011, Pages 405-411

  Le, Thanh Hoa ^a   Le, Tran Binh ^a   Doan, Thanh Huong Thi ^a   van Quyen, Dong ^a   Le, Kim Xuyen Thi ^a   Pham, Viet Cuong ^a   Nagataki, Mitsuru ^b   Nomura, Haruka ^c   Ikeue, Yasunori ^b   Watanabe, Yoshiya ^b   Agatsuma, Takeshi ^c  

^a INSTITUTE OF BIOTECHNOLOGY   (Viet Nam)

^b Research and Development Division   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

A H5N1 vaccine; A H5N2 vaccine; Avian influenza; Immunogenicity; Immunomodulation; Sophy glucan (SBG)

Indexed keywords

AVIAN INFLUENZA VACCINE; BETA GLUCAN; SOPHY BETA GLUCAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHICKEN; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUCK; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TEST; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; NONHUMAN; POULTRY; SINGLE DRUG DOSE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; ASCOMYCOTA; BETA-GLUCANS; CHICKENS; DUCKS; HEMAGGLUTINATION INHIBITION TESTS; IMMUNIZATION; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY DISEASES; VACCINES, INACTIVATED;

ANAS; ANIMALIA; AUREOBASIDIUM PULLULANS; AVES; AVIAN INFLUENZA VIRUS; CAIRINA MOSCHATA; CHAETOTHYRIALES; GALLUS GALLUS;

EID: 79955748249     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1011.11024     Document Type: Article

References (28)

1. Allan, W. H., J. E. Lancaster, and B. Toth. 1978. Newcastle disease vaccines, their production and use, pp. 57-62. In: FAO Animal Production Health, Series-10. United Nations, Rome.
2. Brown, G. D. and S. Gordon. 2005. Immune recognition of fungal β-glucans [Review]. Cell Microbiol. 7: 471-479.
3. Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, S. Y. C. Wong, and S. Gordon. 2002. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196: 407-412.
4. Chae, B. J., J. D. Lohakare, W. K. Moon, S. L. Lee, Y. H. Park, and T. W. Hahn. 2006. Effects of supplementation of β-glucan on the growth performance and immunity in broilers. Res. Vet. Sci. 80: 291-298.
5. Chen, J. and R. Seviour. 2007. Medicinal importance of fungal b-(1/3), (1/6)-glucans. Mycol. Res. 111: 635-652.
6. Cheng, Y., D. Lee, C. Wen, and C. Weng. 2004. Effects of betaglucan supplementation on lymphocyte proliferation, macrophage chemotaxis and specific immune responses in broilers. Asian- Aust. J. Anim. Sci. 17: 1145-1149.
7. Dillon, S., S. Agrawal, K. Banerjee, J. Letterio, T. L. Denning, K. Oswald-Richter, et al. 2006. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116: 916-928.
8. DiNapoli, J. M., L. Yang, A. J.r. Suguitan, S. Elankumaran, D. W. Dorward, B. R. Murphy, S. K. Samal, P. L. Collins, and A. Bukreyev. 2007. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J. Virol. 81: 11560-11568.
9. Dung Nguyen, T., T. Vinh Nguyen, D. Vijaykrishna, R. G. Webster, Y. Guan, J. S. M. Peiris, and G. J. Smith. 2008. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg. Infect. Dis. 14: 632-636.
10. Goetz, S. K., E. Spackman, C. Hayhow, and D. E. Swayne. 2008. Assessment of reduced vaccine dose on efficacy of an inactivated avian influenza vaccine against an H5N1 highpathogenicity avian influenza virus. J. Appl. Poult. Res. 17: 145-150.
11. Hobson, D., R. L. Curry, A. S. Beare, and A. Ward-Gardner. 1972. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. 70: 767-777.
12. Huff, G. R., W. E. Huff, N. C. Rath, and G. Tellez. 2006. Limited treatment with beta-1,3/1,6-glucan improves production values of broiler chickens challenged with Escherichia coli. Poult. Sci. 85: 613-618.
13. Ichinohe, T., A. Ainai, T. Nakamura, Y. Akiyama, J. Maeyama, T. Odagiri, et al. 2010. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia. J. Med. Virol. 82: 128-137.
14. Ikewaki, N., N. Fujii, T. Onaka, S. Ikewaki, and H. Inoko. 2007. Immunological actions of Sophy β-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement. Microbiol. Immunol. 51: 861-873.
15. Le, T. H., K. X. T. Le, P. V. Cuong, N. T. K. Cuc, T. B. Le, Y. Ikeue, Y. Watanabe, and T. Agatsuma. 2010. Adjuvant effects of Sophy β-glucan on H5N1 and H5N2 vaccination using a mouse model. Trop. Med. Health 38: 23-27.
16. Li, B., D. Cramer, S. Wagner, R. Hansen, C. King, S. Kakar, C. Ding, and J. Yan. 2007. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways. Clin. Immunol. 124: 170-181.
17. Moro de Sousa, R. L., H. J. Montassier, and A. A. Pinto. 2000. Detection and quantification of antibodies to Newcastle disease virus in ostrich and rhea sera using a liquid phase blocking enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 7: 940-944.
18. Peyre, M., G. Fusheng, S. Desvaux, and F. Roger. 2009. Avian influenza vaccines: A practical review in relation to their application in the field with a focus on the Asian experience. Epidemiol. Infect. 137: 1-21.
19. Soltanian, S., E. Stuyven, E. Cox, P. Sorgeloos, and P. Bossier. 2009. βGlucans as immunostimulant in vertebrates and invertebrates. Crit. Rev. Microbiol. 35: 109-138.
20. Suzuki, Y., Y. Adachi, N. Ohno, and T. Yadomae. 2001. Th1/ Th2-Balancing immunomodulating activity of gel-forming (1-->3)- β-glucans from fungi. Biol. Pharm. Bull. 24: 811-819.
21. Swayne, D. E. 2006. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza Emphasis on asian H5N1 high pathogenicity avian influenza. Ann. N.Y. Acad. Sci. 1081: 174-181.
22. Swayne, D. E., J. R. Beck, M. Garcia, and H. D. Stone. 1999. Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathol. 28: 245-255.
23. Takahashi, Y., H. Hasegawa, Y. Hara, M. Ato, A. Ninomiya, H. Takagi, et al. 2009. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice. J. Infect. Dis. 199: 1629-1637.
24. Taylor, P. R., G. D. Brown, D. M. Reid, J. A. Willment, L. Martinez-Pomares, S. Gordon, and S. Y. C. Wong. 2002. The β-glucan receptor Dectin-1 is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169: 3876-3882.
25. Tian, G., S. Zhang, Y. Li, Z. Bu, P. Liu, J. Zhou, et al. 2005. Protective efficacy in chickens, geese and ducks of an H5N1- inactivated vaccine developed by reverse genetics. Virology 341: 153-162.
26. Wasser, S. P. and A. L. Weis. 1999. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective. Crit. Rev. Immunol. 19: 65-96.
27. WHO. 2002. Manual on Animal Influenza Diagnosis and Surveillance.
28. Yoon, H. S., J. W. Kim, H. R. Cho, S. B. Moon, H. D. Shin, K. J. Yang, H. S. Lee, Y. S. Kwon, and S. K. Ku. 2010. Immunomodulatory effects of Aureobasidium pullulans SM- 2001 exopolymers on cyclophosphamide-treated mice. J. Microbiol. Biotechnol. 20: 433-440.